- Home
- GVH vs MDCX Comparison
GVH vs MDCX Comparison
Compare GVH & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GVH | MDCX |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | Australia | United States |
| Employees | N/A | 12 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5M | 13.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GVH | MDCX |
|---|---|---|
| Price | $6.00 | $0.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $80.00 | $14.50 |
| AVG Volume (30 Days) | 150.7K | ★ 2.9M |
| Earning Date | 02-17-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $102,768.97 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.03 | $0.27 |
| 52 Week High | $10.74 | $8.90 |
Technical Indicators
Market Signals| Indicator | GVH | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 85.92 | 29.82 |
| Support Level | $4.02 | N/A |
| Resistance Level | N/A | $0.52 |
| Average True Range (ATR) | 0.65 | 0.02 |
| MACD | 0.23 | 0.01 |
| Stochastic Oscillator | 89.05 | 23.03 |
Price Performance
Historical ComparisonAbout GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.